Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
211.05 (1y: +0%)
Market Cap 425.37 M P/E(ttm) 18.10
Enterprise Value 404.94 M P/B 3.16
ATRI- NAS (USA)
Atrion Corporation
  • Currently 5/5
Business Predictability Rank: 5-Star (On Watch)
Back Testing Results:
Average gain of all 5-Star stocks: 12.1% per year.
% of Stocks that are in still loss if held for 10yrs: 3%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$211.05
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry		 vs
history
Cash to Debt No Debt
ATRI's Cash to Debt is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.43 vs. ATRI: No Debt )
ATRI' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt
Equity to Asset 0.798
ATRI's Equity to Asset is ranked higher than
85% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.47 vs. ATRI: 0.798 )
ATRI' s 10-Year Equity to Asset Range
Min: 0.38   Max: 0.8
Current: 0.8
0.38
0.8
Interest Coverage No Debt
ATRI's Interest Coverage is ranked higher than
59% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.10 vs. ATRI: No Debt )
ATRI' s 10-Year Interest Coverage Range
Min: 7   Max: No Debt
Current: No Debt
F-Score: 4
Z-Score: 14.62
M-Score: -1.72
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry		 vs
history
Operating margin (%) 28.20
ATRI's Operating margin (%) is ranked higher than
96% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.00 vs. ATRI: 28.20 )
ATRI' s 10-Year Operating margin (%) Range
Min: 6.4   Max: 32.4
Current: 28.2
6.4
32.4
Net-margin (%) 19.8
ATRI's Net-margin (%) is ranked higher than
95% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.30 vs. ATRI: 19.8 )
ATRI' s 10-Year Net-margin (%) Range
Min: 4.3   Max: 22.1
Current: 19.8
4.3
22.1
ROE (%) 17.5
ATRI's ROE (%) is ranked higher than
88% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. ATRI: 17.5 )
ATRI' s 10-Year ROE (%) Range
Min: 5.4   Max: 24.9
Current: 17.5
5.4
24.9
ROA (%) 15.2
ATRI's ROA (%) is ranked higher than
94% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. ATRI: 15.2 )
ATRI' s 10-Year ROA (%) Range
Min: 3.6   Max: 16.1
Current: 15.2
3.6
16.1
ROC (Joel Greenblatt) (%) 36.30
ATRI's ROC (Joel Greenblatt) (%) is ranked higher than
74% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 14.00 vs. ATRI: 36.30 )
ATRI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 7.8   Max: 44.8
Current: 36.3
7.8
44.8
Revenue Growth (%) 4.1
ATRI's Revenue Growth (%) is ranked higher than
65% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.40 vs. ATRI: 4.1 )
ATRI' s 10-Year Revenue Growth (%) Range
Min: 4.1   Max: 13.9
Current: 4.1
4.1
13.9
EBITDA Growth (%) 6.3
ATRI's EBITDA Growth (%) is ranked higher than
85% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.50 vs. ATRI: 6.3 )
ATRI' s 10-Year EBITDA Growth (%) Range
Min: 6.3   Max: 18.8
Current: 6.3
6.3
18.8
EPS Growth (%) 8.7
ATRI's EPS Growth (%) is ranked higher than
86% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.15 vs. ATRI: 8.7 )
ATRI' s 10-Year EPS Growth (%) Range
Min: -5   Max: 35.3
Current: 8.7
-5
35.3
» ATRI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

ATRI Guru Trades in Q2 2012

Jim Simons 5,300 sh (+32.5%)
Chuck Royce 223,445 sh (-1.63%)
» More
Q3 2012

ATRI Guru Trades in Q3 2012

Jim Simons 5,600 sh (+5.66%)
Chuck Royce 228,245 sh (+2.15%)
» More
Q4 2012

ATRI Guru Trades in Q4 2012

Jim Simons 6,200 sh (+10.71%)
Chuck Royce 225,574 sh (-1.17%)
» More
Q1 2013

ATRI Guru Trades in Q1 2013

Chuck Royce 244,957 sh (+8.59%)
Jim Simons 6,500 sh (+4.84%)
» More
» Details

Insider Trades

Latest Guru Trades with ATRI



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/E(ttm) 18.10
ATRI's P/E(ttm) is ranked higher than
81% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.40 vs. ATRI: 18.10 )
ATRI' s 10-Year P/E(ttm) Range
Min: 4.57   Max: 20.2
Current: 18.1
4.57
20.2
P/B 3.10
ATRI's P/B is ranked lower than
54% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. ATRI: 3.10 )
ATRI' s 10-Year P/B Range
Min: 0.52   Max: 3.8
Current: 3.1
0.52
3.8
P/S 3.70
ATRI's P/S is ranked lower than
66% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. ATRI: 3.70 )
ATRI' s 10-Year P/S Range
Min: 0.46   Max: 4.47
Current: 3.7
0.46
4.47
PFCF 22.40
ATRI's PFCF is ranked higher than
63% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.35 vs. ATRI: 22.40 )
ATRI' s 10-Year PFCF Range
Min: 4.93   Max: 429.32
Current: 22.4
4.93
429.32
EV-to-EBIT 12.2
ATRI's EV-to-EBIT is ranked higher than
77% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.12 vs. ATRI: 12.2 )
ATRI' s 10-Year EV-to-EBIT Range
Min: 4.6   Max: 18.5
Current: 12.2
4.6
18.5
PEG 1.7
ATRI's PEG is ranked higher than
95% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. ATRI: 1.7 )
ATRI' s 10-Year PEG Range
Min: 0.28   Max: 1.7
Current: 1.7
0.28
1.7
Shiller P/E 20.2
ATRI's Shiller P/E is ranked higher than
75% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.85 vs. ATRI: 20.2 )
ATRI' s 10-Year Shiller P/E Range
Min: 11.46   Max: 29.95
Current: 20.2
11.46
29.95

Dividend & Buy Back

vs
industry		 vs
history
Dividend Yield 1.00
ATRI's Dividend Yield is ranked higher than
73% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. ATRI: 1.00 )
ATRI' s 10-Year Dividend Yield Range
Min: 0.25   Max: 1.74
Current: 1
0.25
1.74
Dividend Payout 0.1967
ATRI's Dividend Payout is ranked higher than
95% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.53 vs. ATRI: 0.1967 )
ATRI' s 10-Year Dividend Payout Range
Min: 0.09   Max: 0.18
Current: 0.2
0.09
0.18
Dividend growth (3y) 12.3
ATRI's Dividend growth (3y) is ranked higher than
98% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. ATRI: 12.3 )
ATRI' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 32.5
Current: 12.3
0
32.5
Yield on cost (5-Year) 2.29
ATRI's Yield on cost (5-Year) is ranked higher than
93% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. ATRI: 2.29 )
ATRI' s 10-Year Yield on cost (5-Year) Range
Min: 0.57   Max: 3.98
Current: 2.29
0.57
3.98
Share Buyback Rate -0.1
ATRI's Share Buyback Rate is ranked higher than
73% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -1.70 vs. ATRI: -0.1 )
ATRI' s 10-Year Share Buyback Rate Range
Min: 8.3   Max: -1.8
Current: -0.1

Valuation & Return

vs
industry		 vs
history
Price/Net Current Asset Value 22.1
ATRI's Price/Net Current Asset Value is ranked higher than
72% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.40 vs. ATRI: 22.1 )
ATRI' s 10-Year Price/Net Current Asset Value Range
Min: 10.1   Max: 321.4
Current: 22.1
10.1
321.4
Price/Tangible Book 3.4
ATRI's Price/Tangible Book is ranked higher than
62% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. ATRI: 3.4 )
ATRI' s 10-Year Price/Tangible Book Range
Min: 1.1   Max: 3.8
Current: 3.4
1.1
3.8
Price/DCF (Projected) 1.3
ATRI's Price/DCF (Projected) is ranked higher than
85% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. ATRI: 1.3 )
ATRI' s 10-Year Price/DCF (Projected) Range
Min: 0.8   Max: 3.4
Current: 1.3
0.8
3.4
Price/Median PS Value 1.9
ATRI's Price/Median PS Value is ranked higher than
97% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.90 vs. ATRI: 1.9 )
ATRI' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 2.2
Current: 1.9
0.3
2.2
Price/Peter Lynch Fair Value 1.7
ATRI's Price/Peter Lynch Fair Value is ranked lower than
61% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. ATRI: 1.7 )
ATRI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.7   Max: 1.5
Current: 1.7
0.7
1.5
Price/Graham Number 1.7
ATRI's Price/Graham Number is ranked higher than
69% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.30 vs. ATRI: 1.7 )
ATRI' s 10-Year Price/Graham Number Range
Min: 0.8   Max: 1.8
Current: 1.7
0.8
1.8
Earnings Yield (Greenblatt) 8.20
ATRI's Earnings Yield (Greenblatt) is ranked higher than
85% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. ATRI: 8.20 )
ATRI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.4   Max: 21.6
Current: 8.2
5.4
21.6
Forward Rate of Return (Yacktman) 14.29
ATRI's Forward Rate of Return (Yacktman) is ranked higher than
73% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.11 vs. ATRI: 14.29 )
ATRI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 15   Max: 35.6
Current: 14.29
15
35.6

Business Description

Atrion Corporation and its subsidiaries develop and manufacture products, mainly for medical applications. Its medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include proprietary valves that promote infection control and needle safety. It has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. It also make tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications including anesthesia and oncology. Its cardiovascular products include MPS2 Myocardial Protection System, or MPS2, a proprietary technology that delivers essential fluids and medications to the heart during open-heart surgery. The MPS2 integrates key functions relating to the delivery of solutions to the heart, such as varying the rate and ratio of oxygenated blood, crystalloid, potassium and other additives, and controlling temperature, pressure and other variables to allow simpler, more flexible management of this process, indicating improved patient outcomes. The MPS2 is the only device used in open-heart surgery that allows for the mixing of drugs into the bloodstream without diluting the blood. The MPS2 employs advanced pump, temperature control and microprocessor technologies and includes a line of disposable products. It also develop and manufacture other cardiovascular products such as cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; inflation devices for balloon catheter dilation, stent deployment and fluid dispensing; as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The Company is a manufacturer of contact lens disinfection cases. It also manufacture a proprietary line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Nasolacrimal duct obstruction can cause a condition called epiphora, or chronic tearing. People affected by this condition experience excessive and uncontrollable tearing and often encounter infection as a result of nasolacrimal blockage. In addition, it manufactures and sells a line of products designed for safe needle and scalpel blade containment. It is also the manufacturer of inflation systems and valves used in marine and aviation safety products. It manufactures inflation systems and valves for products such as life vests, life rafts, inflatable boats, survival equipment, and other inflatable structures. It also produce one-way and two-way pressure relief valves for use on electronics cases, munitions cases, pressure vessels, transportation contain
Company Website
SEC Reports
Industry: Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO
» More Articles for ATRI

Headlines

Articles On GuruFocus.com
The Newly Rebalanced Buffett-Munger Portfolio Jan 02 2013 
Buffett-Munger Model Portfolio Posts Fourth Solid Year, Hits Refresh for 2013 Dec 14 2012 
Atrion Corporation: Track Record of Delivery Dec 03 2012 
How to Look Beyond Dividend Increases Aug 27 2012 
The Best Stocks With Dividend Growth From Last Week (August 20 – August 26, 2012) Aug 26 2012 
10 High Margin Healthcare Dividend Shares Jan 02 2012 
9 Dividend Stocks Providing Positive Feedback Aug 22 2011 
Guru Stocks Raising Dividends: ITC, PCBK, ATRI, NDSN Aug 22 2011 
ATRION Corp. Reports Operating Results (10-Q) Nov 04 2010 
3 Signs of an Impending Dividend Cut Aug 09 2010 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial